Renal impairment associated with tenofovir disoproxil fumarate for antiretroviral therapy and HIV pre-exposure prophylaxis: An observational cohort study.
Jack E HeronHamish McManusTobias VickersKathleen RyanEdwina WrightAllison CarterMark StooveJason AsselinAndrew GrulichBasil DonovanRebecca GuyRick VarmaMarcus ChenNathan RyderDavid A LewisDavid J TempletonCatherine C O'ConnorDavid M Graceynull nullPublished in: PloS one (2023)
Patients prescribed TDF-based PrEP had lower rates of renal impairment than patients prescribed TDF for HIV infection. In propensity analysis, after matching for some risk factors, rates of renal impairment remained higher amongst patients with HIV.
Keyphrases
- antiretroviral therapy
- hiv infected
- end stage renal disease
- hiv positive
- human immunodeficiency virus
- hiv aids
- risk factors
- newly diagnosed
- ejection fraction
- hiv infected patients
- chronic kidney disease
- peritoneal dialysis
- hepatitis c virus
- men who have sex with men
- hiv testing
- patient reported outcomes
- patient reported
- data analysis